Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients

Background: Amyotrophic lateral sclerosis (ALS) is a multisystemic, progressive, neurodegenerative disorder. Despite it being generally fatal within a period of 2–4 years, it is highly heterogeneous; as a result, survival periods may vary greatly among individual patients. Biomarkers can serve as to...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Mingot, Cristina, Miana-Mena, Francisco Javier, Iñarrea, Pedro José, Iñiguez, Cristina, Capablo, José Luis, Osta, Rosario, Gil-Sánchez, Anna, Brieva, Luis, Larrodé, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219422/
https://www.ncbi.nlm.nih.gov/pubmed/37240666
http://dx.doi.org/10.3390/jcm12103560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219422/
https://www.ncbi.nlm.nih.gov/pubmed/37240666
http://dx.doi.org/10.3390/jcm12103560

Ejemplares similares